Eastern Biopharmaceuticals Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Public

  • Employees
  • 1,480

Employees

  • Stock Symbol
  • 688513

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $5.64
  • (As of Friday Closing)

Eastern Biopharmaceuticals General Information

Description

Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Number 8 Ankang Road, Shuangliu District
  • Chengdu, Sichuan 611731
  • China
+86 028
Primary Industry
Pharmaceuticals
Stock Exchange
SHG
Corporate Office
  • Number 8 Ankang Road, Shuangliu District
  • Chengdu, Sichuan 611731
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eastern Biopharmaceuticals Stock Performance

As of 20-Nov-2026, Eastern Biopharmaceuticals’s stock price is $5.64. Its current market cap is $995M with 176M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.64 $5.84 $5.64 - $11.71 $995M 176M 1.99M $0.23

Eastern Biopharmaceuticals Financials Summary

As of 30-Sep-2026, Eastern Biopharmaceuticals has a trailing 12-month revenue of $189M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,133,120 1,348,153 558,445 902,892
Revenue 188,998 185,139 188,107 157,900
EBITDA 37,365 53,074 44,815 42,911
Net Income 39,537 39,500 33,201 32,025
Total Assets 587,576 542,810 465,765 472,132
Total Debt 30,570 20,959 15,621 31,527
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Eastern Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eastern Biopharmaceuticals‘s full profile, request access.

Request a free trial

Eastern Biopharmaceuticals Patents

Eastern Biopharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026200809-A1 Salt form of γ-aminobutyric acid derivative, crystal form thereof and preparation method therefor Pending 24-Mar-2025
WO-2026124439-A1 Crystal form of benzothiazole derivative, and preparation method therefor and use thereof Pending 10-Dec-2024
WO-2026091339-A1 Chidamide polymorph i and preparation method therefor Pending 29-Oct-2024
WO-2025252109-A1 Substituted tetrahydrofuran derivative, and preparation method therefor and use thereof Pending 04-Jun-2024
WO-2025092695-A1 New heterocyclic covalent inhibitor of menin, preparation method therefor and pharmaceutical use thereof Inactive 31-Oct-2023
To view Eastern Biopharmaceuticals’s complete patent history, request access »

Eastern Biopharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eastern Biopharmaceuticals Investments (2)

Eastern Biopharmaceuticals’s most recent deal was a Later Stage VC with KCI BioTech for . The deal was made on 30-Jun-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
KCI BioTech 30-Jun-2023 Later Stage VC Laboratory Services (Healthcare)
Aubrak Therapeutics 25-Mar-2022 Early Stage VC Drug Discovery
To view Eastern Biopharmaceuticals’s complete investments history, request access »

Eastern Biopharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Eastern Biopharmaceuticals’s complete esg history, request access »

Eastern Biopharmaceuticals Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Eastern Biopharmaceuticals Investment China

Eastern Biopharmaceuticals FAQs

  • When was Eastern Biopharmaceuticals founded?

    Eastern Biopharmaceuticals was founded in 2009.

  • Where is Eastern Biopharmaceuticals headquartered?

    Eastern Biopharmaceuticals is headquartered in Chengdu, China.

  • What is the size of Eastern Biopharmaceuticals?

    Eastern Biopharmaceuticals has 1,480 total employees.

  • What industry is Eastern Biopharmaceuticals in?

    Eastern Biopharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Eastern Biopharmaceuticals a private or public company?

    Eastern Biopharmaceuticals is a Public company.

  • What is Eastern Biopharmaceuticals’s stock symbol?

    The ticker symbol for Eastern Biopharmaceuticals is 688513.

  • What is the current stock price of Eastern Biopharmaceuticals?

    As of 20-Nov-2026 the stock price of Eastern Biopharmaceuticals is $5.64.

  • What is the current market cap of Eastern Biopharmaceuticals?

    The current market capitalization of Eastern Biopharmaceuticals is $995M.

  • What is Eastern Biopharmaceuticals’s current revenue?

    The trailing twelve month revenue for Eastern Biopharmaceuticals is $189M.

  • What is Eastern Biopharmaceuticals’s annual earnings per share (EPS)?

    Eastern Biopharmaceuticals’s EPS for 12 months was $0.23.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process